• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NLRP3炎性小体对急性冠状动脉综合征患者心血管预后的影响。

The effect of NLRP3 inflammasome on cardiovascular prognosis in patients with acute coronary syndrome.

作者信息

Mo De-Gang, Liang Ming-Ting, Xu Li, Li Tai, Han Qian-Feng, Chen Chen, Yao Heng-Chen

机构信息

Department of Cardiology, Qingdao University, Qingdao, 266000, China.

Department of Cardiology, Liaocheng People's Hospital Affiliated to Shandong First Medical University, Liaocheng, 252000, China.

出版信息

Sci Rep. 2025 Jan 7;15(1):1187. doi: 10.1038/s41598-024-85041-4.

DOI:10.1038/s41598-024-85041-4
PMID:39775137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11707183/
Abstract

The NOD‑like receptor protein domain associated protein 3 (NLRP3) inflammasome is critical in inflammatory responses and may be a valuable prognostic biomarker in acute coronary syndrome (ACS). We aimed to investigate the association between NLRP3 inflammasome levels and short-term outcomes in patients with ACS. We enrolled 295 patients with ACS who were monitored for 6 months for major adverse cardiovascular events (MACEs). The NLRP3 inflammasome was quantified using enzyme-linked immunosorbent assays, with the Gensini score used to assess disease severity. A Cox regression model evaluated whether NLRP3 inflammasome levels were independent predictors of MACEs. Spearman correlation analysis demonstrated a significant positive correlation between NLRP3 inflammasome levels and the Gensini score (r = 0.55, p < 0.001). Plasma NLRP3 inflammasome levels were significantly higher in the MACEs group (8.48 ng/mL) compared with the no-MACEs group (3.48 ng/mL) (p < 0.001). Multivariate Cox regression identified NLRP3 inflammasome content as an independent risk factor for MACEs (hazard ratio 1.104, p = 0.001; area under the curve: 0.780 [95% confidence interval 0.721-0.840], p < 0.001). Elevated plasma NLRP3 inflammasome levels correlated with ACS severity and were associated with poorer short-term outcomes in patients with ACS.

摘要

核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)炎性小体在炎症反应中起关键作用,可能是急性冠状动脉综合征(ACS)中有价值的预后生物标志物。我们旨在研究ACS患者中NLRP3炎性小体水平与短期预后之间的关联。我们纳入了295例ACS患者,对其进行了6个月的主要不良心血管事件(MACE)监测。使用酶联免疫吸附测定法对NLRP3炎性小体进行定量,采用Gensini评分评估疾病严重程度。Cox回归模型评估NLRP3炎性小体水平是否为MACE的独立预测因子。Spearman相关性分析表明,NLRP3炎性小体水平与Gensini评分之间存在显著正相关(r = 0.55,p < 0.001)。与无MACE组(3.48 ng/mL)相比,MACE组的血浆NLRP3炎性小体水平显著更高(8.48 ng/mL)(p < 0.001)。多变量Cox回归确定NLRP3炎性小体含量是MACE的独立危险因素(风险比1.104,p = 0.001;曲线下面积:0.780 [95%置信区间0.721 - 0.840],p < 0.001)。血浆NLRP3炎性小体水平升高与ACS严重程度相关,并与ACS患者较差的短期预后相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/11707183/b473b27087a1/41598_2024_85041_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/11707183/12db3c60fda7/41598_2024_85041_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/11707183/49f5f50dfb57/41598_2024_85041_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/11707183/1f22564b3f77/41598_2024_85041_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/11707183/b473b27087a1/41598_2024_85041_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/11707183/12db3c60fda7/41598_2024_85041_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/11707183/49f5f50dfb57/41598_2024_85041_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/11707183/1f22564b3f77/41598_2024_85041_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f00c/11707183/b473b27087a1/41598_2024_85041_Fig4_HTML.jpg

相似文献

1
The effect of NLRP3 inflammasome on cardiovascular prognosis in patients with acute coronary syndrome.NLRP3炎性小体对急性冠状动脉综合征患者心血管预后的影响。
Sci Rep. 2025 Jan 7;15(1):1187. doi: 10.1038/s41598-024-85041-4.
2
Correlation of NLRP3 with severity and prognosis of coronary atherosclerosis in acute coronary syndrome patients.急性冠脉综合征患者中NLRP3与冠状动脉粥样硬化严重程度及预后的相关性
Heart Vessels. 2016 Aug;31(8):1218-29. doi: 10.1007/s00380-015-0723-8. Epub 2015 Aug 20.
3
Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention.通过糖化血红蛋白调整GRACE评分能够更准确地预测接受经皮冠状动脉介入治疗的非糖尿病急性冠状动脉综合征患者的长期主要不良心脏事件。
Cardiovasc Diabetol. 2015 Aug 19;14:110. doi: 10.1186/s12933-015-0274-4.
4
Growth differentiation factor-15 predicts all-cause death and major adverse cardiovascular events in patients with coronary heart disease: a prospective cohort study.生长分化因子 15 可预测冠心病患者的全因死亡和主要不良心血管事件:一项前瞻性队列研究。
J Thromb Thrombolysis. 2024 Oct;57(7):1109-1121. doi: 10.1007/s11239-024-03019-5. Epub 2024 Jul 28.
5
Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.胰岛素抵抗与急性冠状动脉综合征患者冠状动脉病变复杂性及不良心血管转归的关系。
Cardiovasc Diabetol. 2024 May 16;23(1):172. doi: 10.1186/s12933-024-02276-1.
6
Predictive efficacy of neutrophil-to-lymphocyte ratio for long-term prognosis in new onset acute coronary syndrome: a retrospective cohort study.中性粒细胞与淋巴细胞比值对新发急性冠状动脉综合征患者长期预后的预测效能:一项回顾性队列研究。
BMC Cardiovasc Disord. 2020 Nov 30;20(1):500. doi: 10.1186/s12872-020-01773-x.
7
Combined Value of Red Blood Cell Distribution Width and Global Registry of Acute Coronary Events Risk Score for Predicting Cardiovascular Events in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.红细胞分布宽度与急性冠状动脉事件全球注册风险评分联合预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者心血管事件的价值
PLoS One. 2015 Oct 15;10(10):e0140532. doi: 10.1371/journal.pone.0140532. eCollection 2015.
8
Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury.TLR4/Myd88/NF-κB信号通路对冠状动脉微栓塞诱导的心肌损伤中NLRP3炎性小体的影响
Cell Physiol Biochem. 2018;47(4):1497-1508. doi: 10.1159/000490866. Epub 2018 Jun 21.
9
Elevated plasma levels of Mac-2 binding protein predict poor cardiovascular outcomes in patients with acute coronary syndrome.血浆中Mac-2结合蛋白水平升高预示急性冠脉综合征患者心血管预后不良。
Coron Artery Dis. 2017 Dec;28(8):683-689. doi: 10.1097/MCA.0000000000000540.
10
A potential immunotherapy target for breast cancer: parenchymal and immune-stromal expression of the NLRP3 inflammasome pathway.乳腺癌的潜在免疫治疗靶点:NLRP3 炎性小体通路的实质和免疫基质表达。
BMC Cancer. 2023 Nov 29;23(1):1163. doi: 10.1186/s12885-023-11609-4.

引用本文的文献

1
Inflammasome Signaling in Cardiac Arrhythmias: Linking Inflammation, Fibrosis, and Electrical Remodeling.心律失常中的炎性小体信号传导:连接炎症、纤维化和电重构
Int J Mol Sci. 2025 Jun 20;26(13):5954. doi: 10.3390/ijms26135954.

本文引用的文献

1
The prognostic value of HALP score in predicting in-hospital mortality in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.HALP 评分对行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者院内死亡率的预测价值。
Coron Artery Dis. 2023 Nov 1;34(7):483-488. doi: 10.1097/MCA.0000000000001271. Epub 2023 Jul 28.
2
Combining idebenone and rosuvastatin prevents atherosclerosis by suppressing oxidative stress and NLRP3 inflammasome activation.联合使用艾地苯醌和瑞舒伐他汀可通过抑制氧化应激和NLRP3炎性小体激活来预防动脉粥样硬化。
Eur J Pharmacol. 2023 Sep 15;955:175911. doi: 10.1016/j.ejphar.2023.175911. Epub 2023 Jul 13.
3
A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases.
inflammasome 的全景:激活机制、细胞死亡与疾病。
Cell. 2023 May 25;186(11):2288-2312. doi: 10.1016/j.cell.2023.04.025.
4
Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation.NLRP3 炎性小体组装和激活的结构机制。
Annu Rev Immunol. 2023 Apr 26;41:301-316. doi: 10.1146/annurev-immunol-081022-021207. Epub 2023 Feb 7.
5
The NLRP3 inflammasome: activation and regulation.NLRP3 炎性小体:激活与调控。
Trends Biochem Sci. 2023 Apr;48(4):331-344. doi: 10.1016/j.tibs.2022.10.002. Epub 2022 Nov 4.
6
NLRP3 inflammasome contributes to endothelial dysfunction in angiotensin II-induced hypertension in mice.NLRP3 炎性小体在血管紧张素 II 诱导的高血压小鼠的内皮功能障碍中起作用。
Microvasc Res. 2022 Sep;143:104384. doi: 10.1016/j.mvr.2022.104384. Epub 2022 May 24.
7
Role of NLRP3 Inflammasome in Myocardial Ischemia-Reperfusion Injury and Ventricular Remodeling.NLRP3 炎性小体在心肌缺血再灌注损伤及心室重构中的作用。
Med Sci Monit. 2022 Jan 19;28:e934255. doi: 10.12659/MSM.934255.
8
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 ACC/AHA/SCAI 冠状动脉血运重建指南:执行摘要:美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。
Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039. Epub 2021 Dec 9.
9
Inhibition of the Inflammasome Activity of NLRP3 Attenuates HDM-Induced Allergic Asthma.抑制 NLRP3 炎性小体的活性可减轻 HDM 诱导的变应性哮喘。
Front Immunol. 2021 Aug 3;12:718779. doi: 10.3389/fimmu.2021.718779. eCollection 2021.
10
WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study.白细胞计数可预测糖尿病合并冠心病患者的心力衰竭:一项回顾性队列研究。
ESC Heart Fail. 2021 Oct;8(5):3748-3759. doi: 10.1002/ehf2.13513. Epub 2021 Jul 15.